Cephapirin (CAS 21593-23-7)

Cephapirin, a first-generation cephalosporin antibiotic, has been extensively studied in scientific research for its antimicrobial activity and mechanism of action. Recent investigations have revealed that cephapirin exerts its bactericidal effects by inhibiting bacterial cell wall synthesis. Specifically, cephapirin targets penicillin-binding proteins (PBPs) located on the bacterial cell membrane. Among these PBPs, PBP3 plays a crucial role in the final stages of peptidoglycan synthesis, facilitating the cross-linking of peptidoglycan chains to form the bacterial cell wall. By binding to PBP3, cephapirin interferes with this cross-linking process, leading to the weakening of the bacterial cell wall and eventual cell lysis. Furthermore, cephapirin has been utilized as a valuable tool in microbiology research to study bacterial cell wall biosynthesis and mechanisms of antibiotic resistance. Researchers have also explored the structural modifications of cephalosporin antibiotics, including cephapirin, aiming to optimize their pharmacological properties and enhance their efficacy against resistant bacterial strains. Additionally, cephapirin′s mechanism of action against bacterial cell wall synthesis offers valuable insights into bacterial cell biology and potential approaches for combating antibiotic resistance, making it an essential component in antimicrobial research.